(Q33366747)

26 July 2017

title

Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura (English)

1 reference

Immune thrombocytopenic purpura

26 July 2017

1 reference

1 reference

1 reference

1 reference

Sandeep K Rajan

1

1 reference

26 July 2017

Byron M Espina

series ordinal

2

1 reference

26 July 2017

Howard A Liebman

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

129

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

818-824

1 reference

Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Diffuse recidivant alveolar hemorrhage in a patient with hepatitis C virus-related mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Autoimmune thrombocytopenia associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Thrombocytopenia during interferon alfa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Autoimmune thrombocytopenia and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Thrombocytopenia associated with hepatitis C viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Hepatitis C virus infection and autoimmune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Treatment of hepatitis C related thrombocytopenia with interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Interferon increases serum thrombopoietin in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05542.X

10.1111/J.1365-2141.2005.05542.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference